IQV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IQVIA Holdings Inc (IQV) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 to invest. The stock has strong financial performance, positive sentiment from analysts, and recent purchases by Congress members, indicating confidence in the company's future. Despite some insider and hedge fund selling, the long-term growth prospects and favorable analyst ratings outweigh the negatives.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 58.21, suggesting no overbought or oversold conditions. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a longer-term downtrend. The stock is trading near its resistance level (R1: 171.189), which could act as a short-term barrier.
Analysts have upgraded the stock with higher price targets, citing strong execution, unique data analytics capabilities, and an attractive risk/reward profile.
Congress members have made significant purchases in the stock, indicating confidence.
Financial performance in Q4 2025 showed strong revenue, net income, and EPS growth.
Hedge funds and insiders are selling the stock at an increased rate, which could indicate caution.
Gross margin declined by -5.60% YoY in Q4
The stock's moving averages indicate a bearish trend, and it is trading near resistance levels.
In Q4 2025, revenue increased by 10.26% YoY to $4.36 billion, net income rose by 17.62% YoY to $514 million, and EPS grew by 23.55% YoY to $2.99. However, gross margin dropped by -5.60% YoY to 25.64%. Overall, the company demonstrated strong growth in key financial metrics.
Analysts have recently upgraded the stock to Buy or Overweight ratings, with price targets ranging from $210 to $221. They highlight the company's ability to benefit from increased clinical trial activity and its strong data analytics capabilities. The stock is seen as undervalued, with significant upside potential.
